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An in-vitro evaluation of the antioxidant activities of wild Palestinian Pistacia palaestina extracts was 
done. In parallel, the total phenolic content (TPC) and the total flavonoids content (TFC) were measured. 
The antioxidant activities were determined spectrophotometrically by DPPH, FRAP, CUPRAC and the 
ABTS methods. The phenolic and flavonoid contents were separated and identified using LC-PDA-MS. 
The P. palaestina extract was found to contain many phenolic and flavonoids that enhance its reducing 
activity and free radical scavenging ability. Total phenolic content, and total flavonoids contents were 
found to be 66.5 ± 2.2 mg Gallic acid/g, and 20.3 ± 1.1 mg catechin/g, respectively. Antioxidant activity 
represented as FRAP, CUPRAC, DPPH and ABTS was found to be 23.5± 1.2 mmol Fe
+2
/g, 4562 ± 63 µmol 
Trolox/g, 344 ± 11 µmol/g, 53.1 ± 6.6 µmol/g, respectively. The aim of the study is therefore to employ 
different antioxidant tests to evaluate the antioxidant activities of crude ethanol leaf extracts of P. 
palaestina, and to determine its phenolic and flavonoids content.  
 
Key words: Pistacia palaestina, flavonoids, antioxidants, Liquid chromatography–mass spectrometry (LC-MS). 
 
 
INTRODUCTION 
 
Humans face different environmental stressors that 
increase the release of reactive oxygen species (ROS) in 
the body (Pryor and Stone, 1993; Flora, 2007). These 
stress conditions include ultraviolet (UV) radiation, 
microorganisms of different allergens, rise in ozone, 
cigarette smoke, and polycyclic aromatic hydrocarbons 
(Pryor and Stone, 1993). Free radicals are non-stable 
compounds rich with energy and have  electrons  that  do 
not form pairs in their external atomic orbitals. They are 
formed by removing or adding an electron from a non-
radical atom or molecule (Flora, 2007). Radicals are very 
reactive because they have reductive or oxidizing effects 
in the body by giving or taking electrons to or from other 
molecules. ROS forms most of the free radicals which are 
known by an oxygen atom with an unshared electron in 
the  external  orbit  (Valko  et  al.,  2007).  Moreover,  free
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oxygen radicals initiate other free radical-forming chain 
reactions with a non-radical or oxygen-centered free 
radical unpaired electron.  This includes superoxide anion 
(O2
.-
), hydroxyl radical (HO
.
), alkoxyl radical (RO
.
), 
peroxyl radical (ROO
.
), hydrogen peroxide (H2O2), 
hypochlorous acid (HOCl), and singlet oxygen (
1
O2), or 
ROS; the free oxygen intermediate product carrier 
metabolite then oxidizes other compounds and initiates 
free radical-forming chain reactions leading to  new free 
radicals (Pham-Huy et al., 2008). 
Biological systems are known to possess antioxidant 
defense system based on enzymatic and non-enzymatic 
mechanism (Valko et al., 2007). Exogenous antioxidant 
sources include vitamin C and E, carotenoids, and of 
course polyphenols.  They are required to achieve 
homeostasis to reflect on maintaining balance between 
oxidant/antioxidant ratio. This becomes essential since 
our endogenous antioxidant system is not sufficient to 
neutralize ROS action during mitochondrial respiration 
system and normal cellular metabolism by depending on 
molecular oxygen such as NADPH oxidase and xanthine 
oxidase. On the contrary, high doses of antioxidants often 
have pro-oxidant activity by enhancing oxidative damage 
(Ullah et al., 2013). 
Natural products derived from plants play a crucial role 
in the development of several clinically useful anticancer 
drugs (Yemmen et al., 2017). Exogenous antioxidants 
have been confirmed to be essential for counteracting 
oxidative stress (Yemmen et al., 2017). These phyto-
antioxidants include phenolic compounds such as 
flavonoids, phenolic acids and alcohols, stilbenes, 
tocopherols, tocotrienols), ascorbic acid and carotenoids 
(Laguerre et al., 2007).  
Polyphenols occur naturally in plants and are of great 
interest for application in food chemistry, pharmacy and 
medicine because of their biological effects benefit (Cook 
et al., 1996). The antioxidant activity of phenolics is 
mainly due to their redox properties, by acting as 
reducing agents (or free radical terminators), hydrogen 
donors, singlet oxygen quenchers and metal chelators 
(Cook et al., 1996). Flavonoids consist of four main 
classes including namely, flavones, flavanones, 
catechins, and anthocyanins and they are classified 
based on their molecular structure (Rice-Evans et al., 
1996). They are well known for   their active antioxidants 
capability. Specifically flavones and catechins are the 
most active flavonoids against ROS (de Groot, 1994; 
Grace, 1994). 
Alternative medicine has been used in many countries 
to treat many illnesses and alleviate pain. This type of 
medicine depends mainly on the medicinal plants which 
are well known sources of bioactive compounds that 
have many pharmacological and medical benefits 
(Sandoval et al., 2002). 
Pistacia palaestina is an evergreen tree belonging to 
the Anacardiaceae family. It is found mostly in the 
Mediterranean area and characterized by poor content  of  
 
 
 
 
nutrient and water and tolerance to long-term exposure of 
extensive solar radiation and elevated temperatures 
(Margaris, 1981). Its mastic has been utilized in folk 
medicine since the time of the ancient Greeks (Ljubuncic 
et al., 2005). The aerial part of this plant is known to 
contain diuretic properties and has been used to treat 
hypertension, coughs, sore throats, eczema, stomach 
aches, kidney stones and jaundice (Ljubuncic et al., 
2005; Bentley and Trimen, 1980; Ljubuncic et al., 2005; 
Khedir et al., 2017; Trabelsi et al, 2012). 
 P. palaestina (also named known as mastaki) has 
antimicrobial, antioxidant, antifungal, and anti-
inflammatory activities (Sofowora, 1982; Paraschos et al., 
2012; Orhan et al., 2006). It has good anti Helicobacter 
pylori effect which helps in curing many gastrointestinal 
diseases (Orhan et al., 2006; Dabos et al., 2010). P. 
palaestina methanolic extract was documented for its 
antimicrobial activity on Escherichia coli bacteria; such 
activity was found to be dose-dependent. Traditionally, P. 
palaestina has been used as an anti-cancer agent 
against prostatic, colon, breast, liver, stomach, spleen, 
and uterus cancers. Furthermore, it helps in the 
protection of the blood vessels as well as the liver by 
inhibiting the Low-density lipoproteins LDL oxidation 
(Rahimi et al., 2009). Thyroid cancer cells were found to 
be sensitive to P. palaestina essential oil and showed a 
remarkable effect as antiproliferative agent while no 
effect was shown on normal fibroblasts. The oil was 
extracted from its mastic gum, twigs, leaves, flowers, and 
berries (Catalani et al., 2017; Mezni et al., 2016). 
Antiproliferative activity of the P. palaestina oil was 
shown to be through in suppressing the NF-κB signal 
pathway and NF-κB activity and inhibited the cell cycle   
at the G1 phase (Giaginis and Theocharis, 2011). 
Therefore the aim of the present study is to employ 
different antioxidant tests to evaluate the antioxidant 
activities of crude ethanol leaf extracts of this plant. 
 
 
MATERIALS AND METHODS 
 
Plant materials 
 
Plant material and extraction  
 
Wild P. palaestina leaves were obtained from Jenin and dried in the 
shade at room temperature for three weeks then grinded to powder. 
Fifty grams of the powder was mixed with 500 ml of 96% Ethanol 
and kept on a shaker for five days at room temperature. The extract 
was filtered using Whatman blue ribbon No. 41 filter paper. The 
filtrate was completely dried under vacuum using rotary evaporator 
(BUCHI Brand) at 50°C. The filtrate was covered to prevent 
atmospheric contamination. A solution of 3 mg/ml concentration 
was prepared and filtered through 0.2 m PVDF membrane filters 
prior to injection to the LC-PDA-MS 
 
 
Chemicals and reagents 
 
This study is a follow up to our earlier publication which lists in 
details all chemicals and reagents including  the  sources  we  used  
 
 
 
 
(Al-Rimawi et al., 2017). All the chemicals and reagents were 
verified to be of analytical grade.  Formic acid and acetonitrile and 
water solvents were of an LC-MS grade from Sigma.  
 
 
Reagents preparation 
 
Ferric reducing ability FRAP reagent was prepared following 
instructions from Benzie and Strain (1999).  Briefly, 2.5 ml of a 10 
mM tripydyltriazine (TPTZ) solution was added to 40 mM HCl and 
2.5 ml of 20 mM FeCl3.6H2O.  This was followed by the addition of 
25 ml of 0.3 M acetate buffer at pH 3.6. Acetate buffer (0.3 M) was 
prepared following the manufacturer’s instructions by dissolving 
16.8 g of acetic acid and 0.8g of sodium hydroxide in 1000 ml of 
distilled water. 
 
 
Chromatographic instrumentation 
 
According to the manufacturer’s description, we used HPLC system 
which is Waters Alliance (e2695 separations module), and it is 
equipped with 2998 Photo diode Array (PDA). It has a data 
acquisition and control compartment which was based on Empower 
3 chromatography data software (Waters, Germany).  Similarly, the 
analyses were performed on a Waters Acquity UPLC H-Class 
system (Waters, Milford, MA, USA) which was equipped with a 
binary solvent manager, sampler manager, column manager, 
Acquity QDa detector and PDA that was connected to Waters 
Empower 3 data station. The Acquity UPLC BEH C18 column (50 
mm × 2.1 mm I.D., 1.7 μm) was equipped with an Acquity BEH C18 
1.7 μm guard column (Vanguard 2.1 × 5 mm).  The entire HPLC 
system was purchased from Waters, Milford, MA, USA.  
 
 
Measurement of antioxidant activity  
 
Ferric reducing/antioxidant power (FRAP) assay  
 
We measured the antioxidant activity in our extracts samples by 
following our earlier protocol (Al-Rimawi et al., 2017) which is  a 
modified method of the assay of ferric reducing/antioxidant power 
(FRAP) published originally by Benzie and Strain (1999).  
Absorbance readings were recorded against at 593 nm and a 
reagent blank. We calibrated the reader using 2 to 5 mM Fe
+2
 
solution and the results were expressed as mmol Fe
+2
/g.  
 
 
Cupric reducing antioxidant power (CUPRAC assay) 
 
The cupric ion reducing antioxidant capacity of the extracts was 
measured following our earlier published protocol (Al-Rimawi et al, 
2017) which is a modification of the method of Apak et al. (2008). In 
this study we measured the antioxidant activity in 100 ul samples 
extract and the absorbance readings were rerecorded at 450 nm 
against the reagent blank. Standard curve was prepared using 
different concentrations of Trolox. The results were expressed as 
µmol Trolox/g.  
 
 
Free radical scavenging activity using DPPH (DPPH assay) 
 
We used DPPH assay in this study based on a protocol with no 
modification that we published earlier (Al-Rimaw et al, 2017). We 
measured the change in the absorbance readings at 515nm for up 
to 30 min or until the steady state was reached. The reagent blank 
contained Methanol (95%). Trolox at different concentrations was 
used to establish the Standard curve. The results were expressed 
as µmol Trolox/g.  
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Free radical scavenging activity using ABTS (2, 2-azino-di-(3-
ethylbenzothialozine-sulphonic acid) 
 
ABTS (2, 2-azino-di-(3-ethylbenzothialozine-sulphonic acid)) 
procedure was followed with minor changes as described by Re et 
al. (1999). The working solution of ABTS+˙ was obtained by diluting 
the stock solution in 99.9% ethanol to give absorption of 0.70 ± 0.02 
at 734 nm. Sample (200 µl) extract was added to 1800 µl of 
ABTS+˙ solution and absorbance readings at 734 nm were taken at 
30°C exactly 10 min after initial mixing (A). The radical-scavenging 
activity of the test samples was expressed as Trolox equivalent 
antioxidant capacity (TEAC) (in µmol Trolox/g sample) as described 
earlier (Al-Rimaw et al., 2017). 
 
 
Total phenolic content (Folin-Ciocalteau) assay) 
 
Total phenolics were determined using Folin-Ciocalteau reagents 
as described in our earlier study (Al-Rimawi et al., 2017). P. 
palaestina plant extracts or gallic acid standard of (40 µl) were used 
in this study as described in our earlier study. Results were 
expressed as mg gallic acid equivalents (GAE)/ g sample. 
 
 
Total flavonoid content 
 
Total flavonoids activity was measured following the colorimetric 
assay of Kim et al. (2003). The absorbance readings were recorded 
at 510 nm. Catechin at 50 - 100 mg/L was used for calibration and 
the final results were expressed as mg catechin equivalents (CEQ)/ 
g sample.  
 
 
Chromatographic conditions 
 
The entire HPLC system was purchased from Waters, Milford, MA, 
USA). The HPLC analytical experiments of the crude ethanol 
extracts were run on Octadecyl column of Waters (XBridge, 4.6 ID 
× 150 mm, 5 μm) as described by the manufacturer. The PDA 
wavelengths range was from 210-500 nm. The flow rate was 1 
ml/min. Injection volume was 20 l and the column temperature 
was set at 25°C. Samples were filtered through 0.45 m micro 
porous disposable filter. 
The LC-MS column and sample temperature were maintained at 
40 and 25°C respectively. Prior to any injection, the mobile phase 
was equilibrated for 4 min. The injection volume was 1 μl. The 
detection range of the PDA was from 210-500 nm. The Acquity 
QDa ionization modes were in the negative and positive ESi, mass 
range was between 100-1200 Da, cone voltage 15V, capillary 
temperature 600˚C, capillary voltage 0.8 KV and sampling rate of 8 
points/second was used. 
 
 
RESULTS             
 
Total phenolic content (TPC) and total flavonoid 
content (TFC) 
 
P. palaestina extract was found to be rich with phenolic 
and flavonoids with TPC and TFC of 66.5 and 20.3 mg/g, 
respectively, as shown in Table 1. 
 
 
Antioxidant activity 
 
Reducing potential of plant extracts 
 
Ferric reducing-antioxidant power (FRAP) assay: This 
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Table 1. Total phenolic content (TPC as mg gallic acid/g DW*), total flavonoids contents (TFC as mg catechin/g DW), FRAP (mmol 
Fe
+2
/g DW), CUPRAC (µmol Trolox/g DW), DPPH (µmol Trolox/g DW), and ABTS (µmol Trolox/g DW) of P. palaestina extract. 
 
TPC
**
 (mg/g) TFC (mg/g) FRAP (mmol/g) CUPRAC (µmol/g) DPPH (µmol/g) ABTS (µmol/g) 
66.5
c
 ± 2.2 20.3
c
 ± 1.1 23.5
c
± 1.2 4562
c
 ± 63 344
c
 ± 11 53.1
c
 ± 6.6 
 
*DW: Dry weight.** Results are expressed as an average of three samples. Different small letters within column indicate significant 
difference (p < 0.05, n = 3). 
 
 
 
method measures the ability of antioxidants to reduce 
ferric irons. It is based on the reduction of the yellow 
complex of ferric irons and 2,3,5-triphenyl-1,3,4-triaza-2-
azoniacyclopenta-1,4-diene chloride (TPTZ) to the blue 
ferrous form by electron-donating substances (such as 
phenolic compounds) at low pH. This reduction is 
monitored by measuring the change in absorption at 593 
nm. The FRAP values can be obtained by comparing the 
absorption change in the test mixture with those obtained 
from increasing concentrations of Fe
2+
. The antioxidant 
test based on FRAP assay of the extract was found to be 
23.5 ±1.2 mmol Fe
+2
/g of dry material (Table 1).  
 
Cupric reducing antioxidant power (CUPRAC): The 
antioxidant test based on CUPRAC assay of the extract 
was found to be 4562 ±63µmole Trolox /g of dry material 
(Table 1). 
 
 
Free radical scavenging ability of plant extracts 
 
Free radical scavenging activity using DPPH 
 
DPPH is a free radical compound and has been widely 
used to test the free radical scavenging ability of various 
samples (31). It is a stable free radical with a 
characteristic absorption at 517 nm that was used to 
study the radical-scavenging effects of the extracts. As 
antioxidants donate protons to this radical, the absorption 
decreases. The antioxidants, on interaction with DPPH, 
either transfer an electron or hydrogen atom to DPPH, 
thus neutralizing its free radical character. The color 
changed from purple to yellow and the absorbance at 
wavelength 517 nm decreased. The DPPH assay is 
based on the ability of the stable free radical 2,2-
diphenyl-1-picrylhydrazyl to react with hydrogen donors 
including phenolics. The bleaching of DPPH solution 
increases linearly with increasing amount of extract in a 
given volume. The DPPH antioxidant activity of the 
extract was found to be 344±11 µmole Trolox/g (Table 1).  
 
 
Free radical scavenging activity using ABTS 
 
A modified procedure using ABTS (2,2-azino-di-(3-
ethylbenzothialozine-sulphonic acid) was used. The 
ABTS
+
˙ stock solution (7 mM) was prepared through 
reaction  of  7 mM  ABTS  and    2.45 mM   of   potassium 
persulphate as the oxidant agent. The working solution of 
ABTS
+
˙ was obtained by diluting the stock solution in 
ethanol to give an absorption of 0.70 ± 0.02 at λ = 734 
nm. Sample extract (100 μl) was added to 900 μl of 
ABTS
+
˙ solution and absorbance readings at 734 nm 
were taken at 30°C exactly 10 min after initial mixing. The 
ABTS assay measures the relative antioxidant ability of 
extracts to scavenge the radical-cation ABTS
+ 
produced 
by the oxidation of 2,2'-azinobis-3-ethylbenzothiazoline-6-
sulphonate. ABTS antioxidant activity of the extract was 
found to be 53.1 ±6.6 µmol Trolox/g (Table 1).  
 
 
HPLC-PDA-MS profiles of P. palaestina extract  
 
The crude extracted ethanolic material of pistacia was 
analyzed using LC-PDA-MS instrument and the UV 
absorption was high at 270 nm (Figure 1). Almost all the 
eluted peaks had two wavelength maxima between 270-
274 nm and close to 338-360 nm (Figure 1). Figure 2 
shows the chromatograms when overlaid at two 
wavelengths of 270 and 350 nm.  When the 
chromatogram is monitored at 270 nm, more peaks were 
seen. 
Table 2 shows some of the deprotonated compounds 
derived from Pistacia palaestina total ion chromatograms 
(Table 2). Besides showing their typical [M-1]
-
 peaks, 
dimer adducts of [2M-1]
-
 were apparently seen because 
of the high concentration of the injected sample (Figure 
3). Figure 3 shows selected MS of flavonoids eluted at 
0.8, 1.2, 1.3, 4, 4.5 and 5.2 min. respectively (3a-f). 
 
 
DISCUSSION  
 
Medicinal plants are good sources of secondary 
metabolites and antioxidants such as phenolic 
compounds (like cinnamic acids, flavonoids, stilbenes, 
coumarins, lignans, and lignins), ascorbic acid and 
carotenoids (Ning et al., 2012). Antioxidants quench free 
radicals and hence prevent cellular damage (Fraige et al., 
2018).  
Traditionally, P. palaestina medicinal plant is used for 
treating many diseases (Sofowora, 1982; Orhan et al., 
2006). It is used as a part of different herbal formulas to 
treat some types of bacterial infections as well as some 
types of cancers (Rahimi et al., 2009; Catalani et al., 
2017; Mezni et al., 2016).  Due  to  absences  of  adverse  
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Figure 1. HPLC-PDA chromatograms of crude P. palaestina ethanol extract at 270 nm. 
 
 
 
 
 
Figure 2. Overlaid HPLC-PDA chromatograms of crude P. palaestina ethanol extract at 270 (red) 
and 350 nm. 
 
Figure 1: HPLC-PDA chromatograms of crude Pistacia palaestina ethanol extract at 270 nm. 
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Table 2. Some of the identified compounds from ethanol extract of Pistacia leaves using UPLC-MS in the 
negative mode. 
 
Peak # RT (mins) [M-H]
-
 MWt Preliminary identification 
1 0.465 191 192 Quinic acid  
2 0.629 343 344 3-Galloylquinic acid 
3 0.666 169 170 Gallic acid 
4 0.827 325 326 5-Galloylshikimic acid 
5 1.19 153 154 Gentisic acid 
6 1.329 495 496 digalloyl quinic acid 
7 2.172 371 372 (17:2)-anacardic acid 
8 2.372 323 324 Unknown 
9 3.052 197 198 Unknown 
10 3.216 523 524 quinic acid derivative 1 
12 3.375 463 464 quercetin 3-O-galactoside 
13 4.085 447 448 kaempferol hexoside 
14 4.395 349 350 Unknown 
15 4.579 615 616 Quercetin 3-(2-galloylglucoside) 
16 4.896 949 950 Unknown 
17 5.023 349 350 Unknown 
18 5.249 599 600 quercetin-O-(O-galloyl)-hexoside 
19 5.848 501 502 Unknown 
20 6.985 327 328 Unknown 
21 7.584 329 330 Unknown 
22 12.042 265 266 Unknown 
 
 
 
effects and good biological activities such as anti-
inflammatory, antimicrobial, and antioxidant activities, its 
application has increased. The results showed that the P. 
palaestina extracts investigated in this study are rich in 
phenolic compounds and flavonoids. These findings 
make this herbal plant an excellent source for 
pharmacological use. The antioxidant activity of P. 
palaestina extract might be attributed to its polyphenols 
content. These natural substances have been proved to 
possess different biological activities (Fraige et al., 2015).  
Until now, there is no antioxidant activity and 
polyphenolic content analysis of P. palaestina from 
Palestine and this motivated us to give more insight into 
the antioxidant and polyphenolic content of this plant. 
Ethanol was used in this work to extract plant materials 
proved to be an effective extraction solvent.  
P. palaestina has strong antioxidant activity 
represented by both acting as reducing agent and as free 
radical scavengers. These results were observed using 
two types of typical assays used to evaluate antioxidant 
activity of plant extracts. The first category measured the 
potential of plant extracts to reduce ions or oxidants (by 
acting as reducing agents) like ferric ion, cupric ion. The 
main two assays of this category are FRAP (which 
measures the reduction potential of ferric to ferrous ion), 
and CUPRAC (which measures the reduction of cupric to 
cuprous ions). Although FRAP antioxidant assay has 
been very popular among  researchers,  CUPRAC  assay 
is a relatively new assay (Apak et al., 2008). It utilizes the 
copper (II)–neocuproine [Cu(II)–Nc] reagent as the 
chromogenic oxidizing agent and is based on the cupric 
reducing ability of reducing compounds to cuprous.  
The second category of AA measures the ability of the 
plant extracts to scavenge free radicals. The DPPH and 
ABTS assays (where DPPH and ABTS are stable free 
radicals) are the two main examples of this category. 
These assays are quick and simple, and their reactions 
are reproducible and linearly related to the concentration 
of the antioxidant(s) present. DPPH is a free radical 
compound and has been widely used to test the free 
radical scavenging ability of various samples (Sakanaka 
et al., 2005). It is a stable free radical with a characteristic 
absorption at 517 nm that was used to study the radical-
scavenging effects of extracts. As antioxidants donate 
protons to this radical, the absorption decreases. 
Antioxidants, on interaction with DPPH, either transfer an 
electron or hydrogen atom to DPPH, thus neutralizing its 
free radical character. The color changed from purple to 
yellow and the absorbance at wavelength 517 nm 
decreased. DPPH assay is based on the ability of the 
stable free radical 2,2-diphenyl-1-picrylhydrazyl to react 
with hydrogen donors including phenolics. The bleaching 
of DPPH solution increases linearly with increasing 
amount of extract in a given volume. 
The UPLC-MS in the negative mode of Pistacia 
palaestina showed various phytochemicals as  phenolics,  
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Figure 3 (a-f). -ESi-MS spectra of flavonoids eluted at 0.8, 1.2, 1.3, 4, 4.5 and 5.2 min respectively. 
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flavonoids and flavonoid glycosides (Al-Rimawi et al., 
2017). This is in agreement with the study of Jouki and 
Khazaei (2010) where different phenolic compounds 
were detected e.g. gallic, chlorogenic, ellagic, sinapic and 
protocatechuic acid, (+)-catechin and juglone (Jouki and 
Khazaei, 2010). The PDA was used to monitor 
wavelengths from 220-360 nm. All the main peaks shared 
maximum wavelengths near 270 nm and close to 338-
360 nm showing glucosides flavonoids. 
 
 
Conclusions 
 
P. palaestina extract is rich in phenolic and flavonoids 
contents and presented an excellent DPPH and ABTS 
radical scavenging activities. It also showed excellent 
reducing abilities as represented by FRAP and CUPRAC 
assays. This activity may be attributed to its polyphenolic 
compounds and flavonoids. The question now is: ‘What 
should be done with the plant or its extracts that are ich in 
PP and flavonoids?’ 
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